About Hematology Consumables
Hematologic consumables are reagents and facility which is used in hematology treatment and therapies. It includes the treatment of blood disorders and malignancies, such as leukemia, hemophilia, lymphoma, and others. Basically, hematology is a branch of internal medicine that deals with the diagnosis, physiology, prognosis, pathology, etiology, treatment, and prevention of blood-related disorders. With the advancement in clinical laboratory service, this market is having strong potential. Along with the rapid adoption of hematology analyzers, the adoption of consumables is also increased.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 7.3% |
There are various companies are exploring in this market are taking various growth initiatives such as mergers & acquisitions, expansions, investments, new product launches and collaborations, and others. There are various new players are entering this market for getting major market share in this industry. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Hematology Consumables market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Bio-Rad Laboratories (United States), HORIBA (Japan), Beckman Coulter (United States), Boule Diagnostics (Sweden), Drew Scientific (United States), Erba Diagnostics, Inc. (Drew Scientific) (United States), Cardinal Health (United States), IDEXX Laboratories, Inc. (United States) and Abbott Laboratories (United States) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Hematology Consumables market by , Application (Infectious Diseases, Blood Screening, Diabetes, HIV, Cancer, Cardiovascular Diseases and Others) and Region.
On the basis of geography, the market of Hematology Consumables has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Sales Channels, the sub-segment i.e. Online Sales Channels will boost the Hematology Consumables market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End Users, the sub-segment i.e. Hospital Laboratories will boost the Hematology Consumables market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Product, the sub-segment i.e. Controls & Calibrators will boost the Hematology Consumables market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Growing Incidence of Blood Disorders Among the Population. and Advancement in Automation in Hematology Instruments
Market Growth Drivers:
Increasing Occurrence of Blood Disorders and the Growing Rate of Blood Donation and Technological Advancement in Hematology Consumables
Challenges:
High Cost Associated with Reagents
Restraints:
Lack of Health Insurance Coverage
Opportunities:
Increasing Number of Diagnostic Centres in Developed Regions and Rapid Adoption of Hematology Consumables by the Laboratories
Market Leaders and their expansionary development strategies
In March 2023, Novartis announced the approval of Adakveo (ciltacabtagene autoleucel) for the treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL).
In January 2024, HORIBA Medical launched HELO 2.0, a high throughput automated hematology platform. This next-generation system is CE-IVDR approved and is pending US FDA approval. It offers a modular solution that is scalable for mid to large-scale laboratories.
Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analyst and Strategic Business Planners, Hematology Consumables Manufacturers and Suppliers, Government Regulatory and Research Organizations and End-Use Industries
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.